NCT03552237

Brief Summary

Background There has been much interest in the relationship between the types of gut microbiota and the development of obesity in recent years. It has been reported that the proportions of Firmicutes and Bacteroidetes differ between obese and normal weight human subjects. Human intestinal microbiota compositions have been found to be associated with long-term dietary habits and lifestyle. However, an increasing number of researches show that intestinal microbiota composition may be affected after short-term diet intervention. Importantly, obesity and metabolic problems play important roles in morbidity and mortality of schizophrenia patients. Human intestinal microbiota compositions related with obesity may impact the heath of this population. Therefore, we searched current advances about the connection of obesity, intestinal microbiota compositions, and diet in schizophrenia to conduct a clinical research focus on the effect of high fiber diet on the intestinal microbiota of schizophrenia patients with central obesity. Method We will investigate in a 4-week intervention whether consumption of dietary fiber supplement(Inulin) affect the microbiota composition in schizophrenia inpatients with central obesity. Fecal samples from participants before and after the intervention will be processed for the microbiota analysis.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started Jun 2018

Shorter than P25 for not_applicable schizophrenia

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 11, 2018

Completed
9 days until next milestone

Study Start

First participant enrolled

June 20, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

June 11, 2018

Status Verified

June 1, 2018

Enrollment Period

3 months

First QC Date

May 15, 2018

Last Update Submit

June 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes from baseline in microbiota composition at week 4

    Fecal samples from participants before and after the intervention will be processed for microbiota analysis

    4 weeks

Study Arms (1)

dietary fiber intervention group

EXPERIMENTAL
Dietary Supplement: dietary fiber

Interventions

dietary fiberDIETARY_SUPPLEMENT

We will investigate in a 4 week intervention whether consumption of dietary fiber supplement affect the microbiota composition in schizophrenia patients with central obesity.

dietary fiber intervention group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Schizophrenia inpatients
  • Overweight and with central obesity
  • agree to sign informed consent

You may not qualify if:

  • Diagnosis of IBS
  • Systemic antibiotic use during the past 4 weeks
  • Excessive water intake

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SchizophreniaObesity, Abdominal

Interventions

Dietary Fiber

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of General Psychiatry Department

Study Record Dates

First Submitted

May 15, 2018

First Posted

June 11, 2018

Study Start

June 20, 2018

Primary Completion

September 20, 2018

Study Completion

December 30, 2018

Last Updated

June 11, 2018

Record last verified: 2018-06